Let's Go
After the High Court intervened, CM Yogi issued the following directive in Lucknow: “No hospital will return the patient; if there is no bed in the government hospital, the patient will be sent to the private hospital, and the state government will bear the entire cost.” Navneet Sehgal ACS Information If the responsible people of … Read more
Recently, a tweet by Shubhash Hudda’s sister caught the attention of the Prime Minister’s Office (PMO) regarding the availability of cancer medicine. Her sister, who is suffering from cancer, had been struggling to obtain the required medication despite the doctor’s prescription. The tweet, which garnered significant attention on social media, highlighted the critical issue of … Read more
Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data, in particular when the data sets are large and complex. As an interdisciplinary field of science, bioinformatics combines biology, computer science, information engineering, mathematics and statistics to analyze and interpret the biological data.Bioinformatics includes biological studies that use computer programming … Read more
Variants of concern and variants of interest are assigned letters from the Greek alphabet for identification. As of July 7, the WHO has identified four in each category. WHO label Variant of Concern Alternative names Country of Discovery alpha B.1.1.7 GRY (formerly 501Y.V1)VOC 202012/01 England beta B.1.351 501Y.V2 South Africa gamma P.1 501Y.V3B.1.1.28.1 Brazil/Japan delta … Read more
Gene therapy is coming to the fore as a way to treat the root cause of disease,rather than just the symptoms. Imagine a world where any genetic disorder can be cured by a single dose of a gene therapy treatment. The best vector for the jobThe goal of gene therapy is to correct disease-causing variations … Read more
Ugur Sahin, an oncologist and mRNA pioneer, discusses development plans for cancer vaccines, mRNA-encoded proteins and more for his firm’s. When Ugur Sahin got to know in January 2020 about the emergent threat of SARS-CoV-2, he immediately started thinking about how BioNTech’s mRNA platform could be used to rapidly deliver a vaccine. His company and … Read more